(ORMP) Oramed Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Oramed Pharmaceuticals | (ORMP) share price targets
Complete technical analysis of Oramed Pharmaceuticals (ORMP) by charts plus indicators, forecast predictions and share price targets for Oramed Pharmaceuticals (ORMP)
Oramed Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-15 View latest technical analysis
10 day averaged volume of Oramed Pharmaceuticals is 113087
| Date | Daily Closing Price | Open | High | Low | Volume |
| 15 Thu Aug 2024 | 2.35 | 2.40 | 2.40 | 2.28 | 1.062 times |
| 14 Wed Aug 2024 | 2.24 | 2.34 | 2.43 | 2.23 | 1.348 times |
| 13 Tue Aug 2024 | 2.36 | 2.35 | 2.43 | 2.30 | 0.55 times |
| 12 Mon Aug 2024 | 2.32 | 2.26 | 2.43 | 2.26 | 0.774 times |
| 09 Fri Aug 2024 | 2.34 | 2.34 | 2.38 | 2.31 | 0.533 times |
| 08 Thu Aug 2024 | 2.37 | 2.27 | 2.40 | 2.22 | 1.055 times |
| 07 Wed Aug 2024 | 2.21 | 2.35 | 2.35 | 2.21 | 0.758 times |
| 06 Tue Aug 2024 | 2.35 | 2.22 | 2.35 | 2.21 | 0.598 times |
| 05 Mon Aug 2024 | 2.21 | 2.13 | 2.33 | 2.10 | 1.804 times |
| 02 Fri Aug 2024 | 2.34 | 2.35 | 2.39 | 2.28 | 1.318 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 2.3 as stoploss in an intra day buy trade for a target of 2.42. However, stock will show a bearish move below 2.3.
Share price targets for Oramed Pharmaceuticals (ORMP)
| Target Type | Value |
| Downside Target | 2.00 |
| Downside Target | 2.10 |
| Downside Target | 2.23 |
| Downside Target | 2.28 |
| Downside Target | 2.35 |
| Upside Target | 2.40 |
| Upside Target | 2.50 |
| Upside Target | 2.60 |
| Upside Target | 2.67 |
| Upside Target | 2.78 |
| Upside Target | 2.95 |
Intraday share price targets for Oramed Pharmaceuticals (ORMP)
| Target Type | Value |
| Downside Intraday Target | 2.24 |
| Downside Intraday Target | 2.14 |
| Upside Intraday Target | 2.44 |
| Upside Intraday Target | 2.54 |
| Downside Intraday Target | 2.34 |
Weekly technical analysis of Oramed Pharmaceuticals (ORMP)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 15 Thu Aug 2024 | 2.35 | 2.26 | 2.43 | 2.23 | 0.786 times |
| 09 Fri Aug 2024 | 2.34 | 2.13 | 2.40 | 2.10 | 0.874 times |
| 02 Fri Aug 2024 | 2.34 | 2.55 | 2.60 | 2.28 | 1.596 times |
| 26 Fri Jul 2024 | 2.60 | 2.55 | 2.67 | 2.52 | 1.022 times |
| 19 Fri Jul 2024 | 2.55 | 2.51 | 2.60 | 2.50 | 0.809 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Oramed Pharmaceuticals (ORMP)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 15 Thu Aug 2024 | 2.35 | 2.46 | 2.52 | 2.10 | 0.645 times |
| 31 Wed Jul 2024 | 2.55 | 2.56 | 2.67 | 2.35 | 0.455 times |
| 28 Fri Jun 2024 | 2.57 | 2.17 | 2.78 | 2.00 | 2.118 times |
| 31 Fri May 2024 | 2.18 | 2.29 | 2.55 | 2.15 | 0.864 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Oramed Pharmaceuticals (ORMP)
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Oramed Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Oramed Pharmaceuticals in short term and the sell signal is strong.
Oramed Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Oramed Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Oramed Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.3 and Oramed Pharmaceuticals (ORMP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Oramed Pharmaceuticals (ORMP) stock. Volume based technical analysis of Oramed Pharmaceuticals (ORMP) stock is negative.
Oramed Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Oramed Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Oramed Pharmaceuticals in short term and the sell signal is strong.
Oramed Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Oramed Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Oramed Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.3 and Oramed Pharmaceuticals (ORMP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Oramed Pharmaceuticals (ORMP) stock. Volume based technical analysis of Oramed Pharmaceuticals (ORMP) stock is negative.
Oramed Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.